New medicines and drug discovery

Nature Reviews Drug Discovery · 14 Oct 2026FDA new drug approvals in Q3 2026Nature Reviews Drug Discovery, Published online: 14 October 2026; doi:10.1038/d41573-026-00164-9 FDA new drug approvals in Q3 2026

Nature Reviews Drug Discovery · 12 Oct 2026Filling the massive AI drug discovery data gapNature Reviews Drug Discovery, Published online: 12 October 2026; doi:10.1038/d41573-026-00137-y Charlotte Deane, co-leader of the OpenBind initiative, discusses the nee…

European Medicines Agency: news · 9 Oct 2026Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 October 2026The Committee adopted a positive opinion for a variation for Mirataz (mirtazapine) to update the product information on the basis of new target animal safety data. The C…

European Medicines Agency: news · 8 Oct 2026Clinical trial applications advice pilot becomes permanentThe Accelerating Clinical Trials in the EU (ACT EU) advice pilot, which helps sponsors prepare clinical trial applications, will become a permanent initiative from Janua…

Nature Reviews Drug Discovery · 7 Oct 2026Next-generation immune cell engagers for B cell depletion in autoimmune diseasesNature Reviews Drug Discovery, Published online: 07 October 2026; doi:10.1038/s41573-026-01534-z Immune cell engagers are emerging as a strategy for deep B cell depletio…

Nature Reviews Drug Discovery · 7 Oct 2026Molecular glue targets ALK resistanceNature Reviews Drug Discovery, Published online: 07 October 2026; doi:10.1038/d41573-026-00163-w Molecular glue targets ALK resistance

FDA: press announcements · 5 Oct 2026FDA Seeks Public Input to Support Ibogaine ResearchFDA Seeks Public Input to Support Ibogaine Research The FDA, an agency within the U.S.

Nature Reviews Drug Discovery · 5 Oct 2026Gene therapy for rare lysosomal storage disorder nabs FDA approvalNature Reviews Drug Discovery, Published online: 05 October 2026; doi:10.1038/d41573-026-00160-z Gene therapy for rare lysosomal storage disorder nabs FDA approval

European Medicines Agency: news · 2 Oct 2026Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 September - 1 OctoberAt its monthly meeting, EMA’s safety committee (PRAC) carried out its broad range of responsibilities to manage the safety of medicines, including the assessment of safe…

FDA: press announcements · 1 Oct 2026FDA Approves First Heart Valve Designed to Grow with ChildrenFDA Approves First Heart Valve Designed to Grow with Children Food and Drug Administration today approved the Autus Size-Adjustable Valve, a surgically implanted pulmona…

European Medicines Agency: news · 1 Oct 2026Advice on ‘end-of-year’ submission dates for type I variations in 2026Marketing authorisation holders are advised to submit any type IB variations or groupings of type IBs and type IAs by 30 November 2026 for a start of procedure in 2026. …

European Medicines Agency: news · 1 Oct 2026EMA Management Board: highlights of September 2026 meetingClinical Trials Information System – preparing for the proposed Biotech Act The Board was updated on progress with the Clinical Trials Information System (CTIS) includin…

Synopses are short, automatically extracted summaries or the publisher’s own description. They may omit important detail. Read the original source before relying on any story. Publishers are listed under “Source”; some, such as The Lancet and NEJM, do not allow automated reading and are not included.